Contact us
Young GI
Patients
Industry
Press
My Connect
Create myUEG account
About
To landing page
Who we are
Boards, Committees & Groups
Governance
Headquarters Management
History
What we do
Strategic Drivers
Year in Review
Our Members
Specialist Member Societies
National Member Societies
myUEG Community
myUEG Associates
My Connect
Women in GI
Young GIs
Researchers
Event Calendar
Week
To landing page
Attendance
Registration fees
Hotel
Venue
Eco-friendly info
Programme
Abstract Submission
Postgraduate Teaching
Nurse Programme
Hands-on
Industry Programme
Acknowledgements
CME Accreditation
UEG Week on-demand
Congress Resources
Education
To landing page
Online Education
Online Courses
Webinars
Career Development
Face-to-face Education
Summer School
Masterclass
Clinical Visiting Fellowships
Education Resources
Mistakes in...
UEG Talks Podcast
Image Hub
CME in Europe
Event Endorsement
Supporters
Research
To landing page
Support
Horizon Europe Support
Projects
Research Prize
Research Fellowship
Research Webinars
Advocacy
Position Papers
White Book 2
Main Results
Full Reports
Materials and Presentations
Quality of Care
To landing page
Search Guidelines
Standards & Guidelines Repository
Non-English Guidelines
GI Guidelines App
Develop & Implement
Guideline development framework
Guideline development course
Get Funding
Get Endorsement
Guideline Webinars
Projects
Quality of Care Initiatives
Quality Standards
Public Affairs
To landing page
Advocacy
Core Positions
Stakeholder Collaboration
White Book 2
Position Papers
MEP Digestive Health Group
Our Supporters
#EUNewsline →
Digestive Health Month
EU Elections 2024
Publications
To landing page
Publications
Congress Publications
Research Publications
Public Affairs Publications
Education Publications
UEG Publications
UEG Journal →
UEG Journal Podcast
White Book 2
Opportunities
To landing page
Congress Opportunities
Top Abstract Prizes
National Scholar Award
Travel Grants
International Scholarship Awards
Research Funding
Research Prize
Research Fellowship
Horizon Europe Application Support
Activities Funding
Recognition of Achievements
Lifetime Achievement Award
Journal Best Paper Award
Activities Endorsement
Professional Advancement
Rising Star Awards
Clinical Visiting Fellowships
Open Positions
Talent Pool
Library
To landing page
Congress Resources
UEG Week on-demand
Abstracts
Posters
Guideline Resources
Education Resources
Image Hub
Webinars
Mistakes in... articles
Contact us
Young GI
Patients
Industry
Press
Author
Mathurin Fumery
EFFECTIVENESS AND SAFETY OF RISANKIZUMAB INDUCTION THERAPY IN PATIENTS WITH CROHN’S DISEASE: A GETAID COHORT STUDY
Mathurin Fumery
et al.
THE BURDEN OF BOWEL URGENCY IN ULCERATIVE COLITIS: A FRENCH MULTICENTRIC REAL-LIFE STUDY (THEFAR)
Mathurin Fumery
et al.
REAL-WORLD COMPARISON OF EFFECTIVENESS BETWEEN USTEKINUMAB AND VEDOLIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS EXPOSED TO AT LEAST ONE ANTI-TNF AGENT
Mathurin Fumery
et al.
COMPARISON OF THE RISK OF CROHN'S DISEASE POSTOPERATIVE RECURRENCE BETWEEN MODIFIED RUTGEERTS SCORE I2A AND I2B CATEGORIES: AN INDIVIDUAL PATIENT DATA META-ANALYSIS
IMPACT OF BIOLOGICS ON THE RISK OF EARLY POSTOPERATIVE COMPLICATIONS IN CROHN'S DISEASE: A FRENCH NATIONWIDE STUDY
Mathurin Fumery
et al.
COLONIC CROHN’S DISEASE IS ASSOCIATED WITH A PEJORATIVE DISEASE COURSE OF PEDIATRIC-ONSET CROHN'S DISEASE: A TWO DECADES POPULATION-BASED STUDY
Mathurin Fumery
et al.
EFFECTIVENESS AND SAFETY OF RISANKIZUMAB INDUCTION THERAPY IN PATIENTS WITH CROHN’S DISEASE: A GETAID COHORT STUDY
PERFUSE: A FRENCH NON-INTERVENTIONAL COHORT STUDY OF ADALIMUMAB-NAÏVE AND TRANSITIONED PATIENTS RECEIVING ADALIMUMAB BIOSIMILAR SB5; BASELINE RESULTS
Mathurin Fumery
et al.
REAL-WORLD MULTICENTER COMPARISON OF SHORT AND LONG-TERM EFFECTIVENESS AND SAFETY BETWEEN TOFACITINIB AND VEDOLIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS AFTER FAILURE TO AT LEAST ONE ANTI-TNF AGENT
Mathurin Fumery
et al.
ULTRASOUND IS EFFECTIVE TO IDENTIFY MUCOSAL HEALING IN CROHN'S DISEASE PATIENTS : RESULTS OF A CROSS-SECTIONAL STUDY
Mathurin Fumery
et al.
LONG-TERM EFFECTIVENESS AND ACCEPTABILITY OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: THE REMSWITCH-LT STUDY
Mathurin Fumery
et al.
COMPLETE ENDOSCOPIC HEALING IS ASSOCIATED WITH LOWER DISABILITY THAN PARTIAL MUCOSAL HEALING IN CROHN’S DISEASE: A PROSPECTIVE MULTICENTRIC STUDY
Mathurin Fumery
et al.
INCREASED INCIDENCE OF CANCER AND MORTALITY IN A PEDIATRIC-ONSET IBD POPULATION-BASED COHORT OF 1344 PATIENTS DIAGNOSED BETWEEN 1988 AND 2011: THE INSPIRED STUDY
Mathurin Fumery
et al.
CHANGING THE COURSE OF CROHN’S DISEASE WITH AN EARLY USE OF ADALIMUMAB: THE CURE STUDY FROM THE GETAID
Mathurin Fumery
et al.
NEW THERAPEUTIC STRATEGIES HAVE CHANGED THE NATURAL HISTORY OF PAEDIATRIC INFLAMMATORY BOWEL DISEASES: RESULTS FROM A POPULATION-BASED COHORT OVER A 24-YEAR PERIOD (1988-2011)
Mathurin Fumery
et al.
REAL-WORLD COMPARISON OF EFFECTIVENESS BETWEEN TOFACITINIB AND USTEKINUMAB IN PATIENTS WITH ULCERATIVE COLITIS EXPOSED TO AT LEAST ONE ANTI-TNF AGENT: LONG-TERM RESULTS FROM THE TORUS STUDY
Mathurin Fumery
et al.
CANCER INCIDENCE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND A PRIOR NON-DIGESTIVE MALIGNANCY ACCORDING TO THE IMMUNOMODULATORY THERAPY: A MULTICENTER COHORT STUDY
Mathurin Fumery
et al.
COMPARATIVE EFFECTIVENESS OF USTEKINUMAB AND ADALIMUMAB IN THE PREVENTION OF POST-OPERATIVE RECURRENCE IN CROHN’S DISEASE
Mathurin Fumery
et al.
NATURAL HISTORY OF ANAL STRICTURE IN PEDIATRIC-ONSET CROHN'S DISEASE: LONG-TERM FOLLOW-UP OF A POPULATION-BASED STUDY
Mathurin Fumery
et al.
EFFECTIVENESS AND SAFETY OF TOFACITINIB IN PATIENTS WITH CHRONIC ANTI-TNF REFRACTORY ULCERATIVE PROCTITIS: A MULTICENTER COHORT STUDY FROM THE GETAID
Mathurin Fumery
et al.
Item 1 - 20 / 24
1
2
Chat with us
, powered by
LiveChat